Suraksha Diagnostic Ltd (SURAKSHA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544293 | NSE: SURAKSHA | Hospital & Healthcare Services | Small Cap

Suraksha Diagnostic Share Price

283.20 2.55 0.91%
as on 05-Dec'25 14:30

Suraksha Diagnostic Ltd (SURAKSHA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544293 | NSE: SURAKSHA | Hospital & Healthcare Services | Small Cap

DeciZen - make an informed investing decision on Suraksha Diagnostic

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Suraksha Diagnostic stock performance -

Key Ratios
mw4me loader
P/E Ratio (CD):
45.78
Market Cap:
1,461.7 Cr.
52-wk low:
233.2
52-wk high:
449

Is Suraksha Diagnostic Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Suraksha Diagnostic: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Suraksha Diagnostic Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'12Mar'13Mar'15Mar'16Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0%0%16.8%16.1%20.2%6%22.7%9.6%22.9%24.9%-
Value Creation
Index
NANA0.20.20.4-0.60.6-0.30.60.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0070.299.1158140223190219252276
Sales YoY Gr.-NANA41.2%58.9%-11.1%59.4%-14.8%15%15.3%-
Adj EPS 00109.378.4217.5115.1358.5119.1372.16.16.1
YoY Gr.-NANA-28.3%177.3%-47.1%211.4%-66.8%212.4%-98.4%-
BVPS (₹) 00695.5775.21,712.51,805.72,149.92,236.22,576.540.544.2
Adj Net
Profit
007.55.4157.924.78.225.73232
Cash Flow from Ops. 0019.513.531.323.542.344.160.563.4-
Debt/CF from Ops. 001.53.10.40.70.50.30.10.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA9.9%4.1%15.3%
Adj EPS NA-51%-74.2%-98.4%
BVPSNA-52.7%-73.4%-98.4%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'12Mar'13Mar'15Mar'16Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0015.310.417.26.517.95.415.316.414.5
Op. Profit
Mgn %
0024.822.221.717.922.224.633.432.630.9
Net Profit
Mgn %
0010.75.59.55.711.14.111.512.411.6
Debt to
Equity
000.60.80.10.10.10.10.100
Working Cap
Days
000786910198102518137
Cash Conv.
Cycle
000-61-30-34-13-11-13-311

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Suraksha Diagnostic Ltd.

Standalone Consolidated
TTM EPS (₹) 6.5 6.1
TTM Sales (₹ Cr.) 269 276
BVPS (₹.) 45 44.2
Reserves (₹ Cr.) 224 220
P/BV 6.24 6.34
PE 43.53 45.78
From the Market
52 Week Low / High (₹) 233.15 / 449.00
All Time Low / High (₹) 233.15 / 449.00
Market Cap (₹ Cr.) 1,462
Equity (₹ Cr.) 10.4
Face Value (₹) 2
Industry PE 90.5

Management X-Ray of Suraksha Diagnostic:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Suraksha Diagnostic - Consolidated Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Suraksha Diagnostic

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales7099157140223190219252
Operating Expenses 5377123117175146148170
Manufacturing Costs5613538474961
Material Costs914212660272730
Employee Cost 1119322334404043
Other Costs 2739586343323136
Operating Profit 1722342348447182
Operating Profit Margin (%) 24.8%22.2%21.7%16.2%21.5%23.4%32.4%32.5%
Other Income 11212444
Interest 1422210109
Depreciation 69131615323335
Exceptional Items -000000-10
Profit Before Tax 12102163373141
Tax 456-091810
Profit After Tax 851562462331
PAT Margin (%) 10.8%5.5%9.7%4.6%10.6%3.2%10.6%12.3%
Adjusted EPS (₹)109.679.7220.593.3344.294.4342.46.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 4955120126150156179211
Share Capital 889999910
Reserves 4147111118141147171201
Minority Interest00000-0-0-1
Debt233381619853
Long Term Debt192981012853
Short Term Debt44077000
Trade Payables1310131314141414
Others Liabilities 1928321618103101107
Total Liabilities 104125173171201281300334

Fixed Assets

Gross Block88116194198211226274319
Accumulated Depreciation1524677992316296
Net Fixed Assets 7391128119119195212223
CWIP 000012111
Investments 00550001
Inventories24546678
Trade Receivables356685914
Cash Equivalents 129443555520
Others Assets 1316243264181757
Total Assets 104125173171201281300334

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 2013312442446063
PBT 12102163373141
Adjustment 612142116404143
Changes in Working Capital 4-63-3-25-4-10
Tax Paid -3-3-7-2-4-7-9-11
Cash Flow From Investing Activity -42-26-20-28-44-21-35-40
Capex -40-27-16-15-19-13-43-42
Net Investments -4-9-3-5-27-115-1
Others 210-1-72334
Cash Flow From Financing Activity 1710-1031-24-25-24
Net Proceeds from Shares 20000000
Net Proceeds from Borrowing 00000000
Interest Paid -1-4-2-2-2-1-1-1
Dividend Paid 00000000
Others 1614-953-23-24-23
Net Cash Flow -6-31-1-0-10-0

Finance Ratio

PARTICULARSMar'15Mar'16Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)15.7610.8417.735.317.44.0113.9315.93
ROCE (%)16.816.1220.196.0422.659.6222.9424.92
Asset Turnover Ratio0.680.871.060.811.20.790.750.8
PAT to CFO Conversion(x)2.52.62.0741.757.332.612.03
Working Capital Days
Receivable Days1413121611121116
Inventory Days111111139121111
Payable Days48729119618280186190173

Suraksha Diagnostic Ltd Stock News

Suraksha Diagnostic Ltd FAQs

The current trading price of Suraksha Diagnostic on 05-Dec-2025 14:30 is ₹283.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Suraksha Diagnostic stood at ₹1,461.7.
The latest P/E ratio of Suraksha Diagnostic as of 04-Dec-2025 is 43.53.
The latest P/B ratio of Suraksha Diagnostic as of 04-Dec-2025 is 6.24.
The 52-week high of Suraksha Diagnostic is ₹449.0 and the 52-week low is ₹233.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Suraksha Diagnostic is ₹269.3 ( Cr.) .

About Suraksha Diagnostic Ltd

Suraksha Diagnostic Limited was incorporated as ‘Suraksha Diagnostic Private Limited’ as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata (RoC). Subsequently, the company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of its Shareholders held on June 5, 2024, and consequently, the name of the company was changed to ‘Suraksha Diagnostic Limited’, and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.

The company offers one-stop integrated solutions for pathology and radiology testing and medical consultation services including X-rays, ultrasonography, computerized tomography, magnetic resonance imaging scans and vaccination services through its operational network, consisting of its flagship central reference laboratory, 8 satellite laboratories (co-located with its diagnostic centers) and 215 customer touchpoints which include 49 diagnostic centres, and 166 sample collection centres (primarily franchised), as of June 30, 2024 across the states of West Bengal, Bihar, Assam, and Meghalaya. It generates revenue primarily through sales of its diagnostic services. It also provides vaccination services, and a broad spectrum of customized test packages, aimed at prediction/early detection of diseases.

In addition to integrated pathology and radiology testing services, it also offers omnichannel medical consultation services via online and offline modes to its customers. The doctors at its polyclinics range across specialties and super-specialties such as cardiology, pediatrics, dermatology, rheumatology, oncology, and nephrology. Its model of polyclinic chambers housed in diagnostic centres providing medical consultation services enables patient convenience through holistic integration of services and offering it the first right to a patient’s prescription leading to higher cross-selling opportunities to the company. It derives the majority of its revenues from the B2C segment.

Business area of the company

The company is primarily engaged in the business of running diagnostic centres for carrying out various pathological and radiological services.

Diagnostic services of the company

  • Routine pathology tests
  • Specialized pathology tests
  • Basic and intermediate radiology tests
  • Advanced radiology tests
  • Preventive and wellness services

Awards, accreditations, and recognition

  • 2017: Best quality in service delivery awarded by ABP News.
  • 2019: Best customer service in healthcare awarded by ABP News. 
  • 2021: Business Leader of the Year organised by World Leadership Congress & Awards and certificate of excellence at the Health Conclave 2021 organised by Zee24 Ghanta.
  • 2022: Awarded the outstanding diagnostic chain of eastern Indian by ABP Ananda. 
  • 2023: Certificate of excellence in exemplary trust and commitment towards diagnostic services at the Health Conclave 2023 organised by Zee24 Ghanta.

History and milestones

  • 2007: Launched the first centre of the Company at Kestopur, West Bengal. 
  • 2010: Launched centre at Khardah, West Bengal and number of operating centres increased to 5. 
  • 2013: Received first round of funding of Rs 300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited. 
  • 2016: Number of laboratories increased to 4 and number of operating centres increased to 25. 
  • 2016: Received second round of funding of Rs 200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company. 
  • 2017: Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs 30 million. 
  • 2019: Expansion of its operations to Meghalaya through a public-private partnership with the Government of Meghalaya. 
  • 2020: Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs 67 million. 
  • 2023: Established its first 3T MRI and 128 CT at New Town.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×